Germ line mutations in Chinese kindreds with von Hippel-Lindau syndrome

Chinese Journal of Medical Genetics

Volumn 24, Issue 2, 2007, Pages 124-127

  Zhang, Jin ^a   Huang, Yi Ran ^a   Pan, Jia Hua ^a   Liu, Dong Ming ^a   Zhou, Li Xin ^a   Xue, Wei ^a   Chen, Qi ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Germ line mutation; VHL gene; Von Hippel Lindau syndrome

Indexed keywords

ARTICLE; CHINESE; EXON; FAMILY ASSESSMENT; GENE DELETION; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; HETEROZYGOTE DETECTION; HUMAN; MISSENSE MUTATION; NONSENSE MUTATION; POLYMERASE CHAIN REACTION; VON HIPPEL LINDAU DISEASE;

ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; CHINA; CODON, NONSENSE; DNA MUTATIONAL ANALYSIS; EXONS; FAMILY HEALTH; FEMALE; GENE DELETION; GERM-LINE MUTATION; HUMANS; MALE; MIDDLE AGED; MUTATION, MISSENSE; PEDIGREE; POLYMERASE CHAIN REACTION; VON HIPPEL-LINDAU DISEASE; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 34247218010     PISSN: 10039406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Maher ER, Iselius L, Yates JR, et al. von Hippel-Lindau disease: a genetic study. J Med Genet, 1991,28:443-447.
2. Latif F, Tory K, Gnarra J, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science, 1993,260:1317-1320.
3. Schoenfeld A, Davidowitz EJ, Burk RD, et al. A second major native von Hippel-Lindau gene product, initiated from an internal translation start site, functions as a tumor suppresor. Proc Natl Acad Sci U S A, 1998,95: 8817-8822.
4. Maher ER. von Hippel-Lindau Disease. Current Mol Medicine, 2004,4: 833-842.
5. Zhang J, Huang YR, Wang JD, et al. Familial and genetic study in a large Chinese kindred with von Hippel-Lindau disease and gene mutation analysis. Chin J Med Genet, 2004,21:5-9.
6. Pan JH, Liu WM, Huang YR, et al. Familial and genetic researches of two Chinese kindred with von Hippel-Lindau disease. Chin J Urol, 2006, 27(Suppl 1):5-8.
7. Neumann HP, Zbar B. Renal cysts, renal cancer and von Hippel-Lindau disease. Kidney Int, 1997,51:16-26.
8. Ashida S, Furihata M, Tanimura M, et al. Molecular detection of von Hippel-Lindau gene mutations in urine and lymph node samples in patients with renal cell carcinoma: potential biomarkers for early diagnosis and postoperative metastatic status. J Urol, 2003,169:2089-2093.
9. Zbar B, Kishida T, Chen F, et al. Germline mutations in the von Hippel-Lindau disease (VHL) gene in families from north America, Europe, and Japan. Hum Mutat, 1996,8:348-357.
10. Yoshida M, Ashida S, Kondo K, et al. Germline mutation analysis in patients with von Hippel-Lindau disease in Japan: an extended study of 77 families. Jpn J Cancer Res, 2000,91:204-212.
11. Lubensky IA, Gnarra JR, Bertheau P, et al. Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients. Am J Pathol, 1996,149:2089-2094.
12. Chen F, Kishida T, Duh FM, et al. Suppression of growth of renal carcinoma cells by the von Hippel-Lindau tumor suppressor gene. Cancer Res, 1995,55:4804-4807.
13. Barry RE, Krek W. The von Hippel-Lindau tumour suppressor: a multifaceted inhibitor of tumourigenesis. Trends Mol Med, 2004,10:466-472.
14. Gallou C, Chauveau D, Richard S, et al. Genotype-phenotype correlation in von Hippel-Lindau families with renal lesions. Hum Mutat, 2004,24: 215-224.
15. Maranchie JK, Afonso A, Albert PS, et al. Solid renal tumor severity in von Hippel-Lindau disease is related to germline deletion length and location. Hum Mutat, 2004,23:40-46.
16. Hes FJ, Lips CJ, van der Luijt RB. Molecular genetic aspects of von Hippel-Lindau disease and criteria for DNA analysis in subjects at risk. Neth J Med, 2001,59:235-243.
17. Catapano D, Muscarella LA, Guarnieri V, et al. Hemangioblastomas of central nervous system: molecular genetic analysis and clinical management. Neurosurgery, 2005,56:1215-1221.